Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease
- 1 June 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Lipidology
- Vol. 18 (3), 263-270
- https://doi.org/10.1097/mol.0b013e32814a645f
Abstract
Adiponectin is secreted exclusively by adipocytes, aggregates in multimeric forms, and circulates at high concentrations in blood. This review summarizes recent studies highlighting cellular effects of adiponectin and its role in human lipid metabolism and atherosclerosis. Adiponectin is an important autocrine/paracrine factor in adipose tissue that modulates differentiation of preadipocytes and favors formation of mature adipocytes. It also functions as an endocrine factor, influencing whole-body metabolism via effects on target organs. Adiponectin multimers exert differential biologic effects, with the high-molecular-weight multimer associated with favorable metabolic effects (i.e. greater insulin sensitivity, reduced visceral adipose mass, reduced plasma triglycerides, and increased HDL-cholesterol). Adiponectin influences plasma lipoprotein levels by altering the levels and activity of key enzymes (lipoprotein lipase and hepatic lipase) responsible for the catabolism of triglyceride-rich lipoproteins and HDL. It thus influences atherosclerosis by affecting the balance of atherogenic and antiatherogenic lipoproteins in plasma, and by modulating cellular processes involved in foam cell formation. Recent studies emphasize the role played by adiponectin in the homeostasis of adipose tissue and in the pathogenesis of the metabolic syndrome, type 2 diabetes, and atherosclerosis. These pleiotropic effects make it an attractive therapeutic target for obesity-related conditions.Keywords
This publication has 95 references indexed in Scilit:
- Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic miceBiochemical and Biophysical Research Communications, 2006
- Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanismBiochemical and Biophysical Research Communications, 2006
- Adiponectin Is an Important Determinant of ApoA-I CatabolismArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazoneBiochemical and Biophysical Research Communications, 2006
- Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Adiponectin inhibits the binding of low-density lipoprotein to biglycan, a vascular proteoglycanBiochemical and Biophysical Research Communications, 2005
- Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophagesBiochemical and Biophysical Research Communications, 2004
- Impaired Multimerization of Human Adiponectin Mutants Associated with DiabetesJournal of Biological Chemistry, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)Biochemical and Biophysical Research Communications, 1996